BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho J, Choi Y, Sajgalik P, No MH, Lee SH, Kim S, Heo JW, Cho EJ, Chang E, Kang JH, Kwak HB, Park DH. Exercise as a Therapeutic Strategy for Sarcopenia in Heart Failure: Insights into Underlying Mechanisms. Cells 2020;9:E2284. [PMID: 33066240 DOI: 10.3390/cells9102284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Giallauria F, Di Lorenzo A, Venturini E, Pacileo M, D'Andrea A, Garofalo U, De Lucia F, Testa C, Cuomo G, Iannuzzo G, Gentile M, Nugara C, Sarullo FM, Marinus N, Hansen D, Vigorito C. Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation. J Clin Med 2021;10:1696. [PMID: 33920796 DOI: 10.3390/jcm10081696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Fu J, Li F, Tang Y, Cai L, Zeng C, Yang Y, Yang J. The Emerging Role of Irisin in Cardiovascular Diseases. J Am Heart Assoc 2021;10:e022453. [PMID: 34622672 DOI: 10.1161/JAHA.121.022453] [Reference Citation Analysis]
3 Barbalho SM, Tofano RJ, Chagas EFB, Detregiachi CRP, de Alvares Goulart R, Flato UAP. Benchside to the bedside of frailty and cardiovascular aging: Main shared cellular and molecular mechanisms. Exp Gerontol 2021;148:111302. [PMID: 33675900 DOI: 10.1016/j.exger.2021.111302] [Reference Citation Analysis]
4 Ding LN, Cheng Y, Xu LY, Zhou LQ, Guan L, Liu HM, Zhang YX, Li RM, Xu JW. The β3 Adrenergic Receptor Agonist CL316243 Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats by Activating AMPK/PGC-1α Signaling in Skeletal Muscle. Diabetes Metab Syndr Obes 2021;14:1233-41. [PMID: 33776460 DOI: 10.2147/DMSO.S297351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen X, Wang Y, Liu M, Song X, Wang D, Zhang J. Network pharmacology-based analysis of the effects of puerarin on sarcopenia. Ann Transl Med 2022;10:671. [PMID: 35845507 DOI: 10.21037/atm-22-2360] [Reference Citation Analysis]
6 Sunayama T, Matsue Y, Dotare T, Maeda D, Iso T, Morisawa T, Saitoh M, Yokoyama M, Jujo K, Takahashi T, Minamino T. Multidomain Frailty as a Therapeutic Target in Elderly Patients with Heart Failure. Int Heart J 2022;63:1-7. [DOI: 10.1536/ihj.21-839] [Reference Citation Analysis]
7 Yingtong M, Wei Z, Hanjun H, Tingting Z, Xiaohua G. The effects of early exercise on cardiac rehabilitation-related outcome in acute heart failure patients: a systematic review and meta-analysis. International Journal of Nursing Studies 2022. [DOI: 10.1016/j.ijnurstu.2022.104237] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Alizadeh Pahlavani H. Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors. Front Endocrinol 2022;13:811751. [DOI: 10.3389/fendo.2022.811751] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 He Y, Xie W, Li H, Jin H, Zhang Y, Li Y. Cellular Senescence in Sarcopenia: Possible Mechanisms and Therapeutic Potential. Front Cell Dev Biol 2021;9:793088. [PMID: 35083219 DOI: 10.3389/fcell.2021.793088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Lu L, Mao L, Feng Y, Ainsworth BE, Liu Y, Chen N. Effects of different exercise training modes on muscle strength and physical performance in older people with sarcopenia: a systematic review and meta-analysis. BMC Geriatr 2021;21:708. [PMID: 34911483 DOI: 10.1186/s12877-021-02642-8] [Reference Citation Analysis]